LOINC description : The Skindex-29 is a patient reported outcome instrument designed to assess the effects
of skin disease in three areas of patient quality of life, symptoms, emotions and
functioning. The Skindex-29 is general in nature and can be used for patients regardless
of specific skin disease. Using on a Likert scale of 1 (Never) to 5 (All the time),
the patient rates the frequency of each skin disease effect over the preceding four
weeks. The Skindex-29 is comprehensive and helpful in understanding the effects of
a specific condition, and its wide use in clinical research allows for data comparison.
Skindex-29 provides a single score for each area (symptoms, emotions and functioning)
as well as an average score. [PMID: 22284137];